GlassScriptPhysician profile
Abigail S Ham
NPI 1528494051
$10,395.29
in general payments reported to CMS, 2019-2025
52 companies · $2,269 in 2025
The $2,269 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $569 · 2023: $3,708 · 2024: $3,723 · 2025: $2,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,615 · Education: $85.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,614.85 |
| Education | $85.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,431.86 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $1,275.58 | 2021-2025 | |
| Ucb, INC. | $910.83 | 2023-2025 | Briviact, Rystiggo, Nayzilam |
| Neurocrine Biosciences, INC. | $658.93 | 2023-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $537.01 | 2022-2025 | |
| Pfizer INC. | $405.61 | 2023-2025 | |
| Sk Life Science, INC. | $398.75 | 2022-2025 | |
| Tg Therapeutics, INC. | $338.01 | 2023-2025 | |
| Celgene Corporation | $223.96 | 2022-2025 | Zeposia |
| Mallinckrodt Hospital Products INC. | $200.46 | 2023-2025 | Acthar |
| Lundbeck LLC | $199.06 | 2023-2025 | Vyepti, Rexulti |
| Astrazeneca Pharmaceuticals LP | $196.79 | 2022-2025 | Wainua, Evusheld |
| Biogen, INC. | $195.75 | 2024-2025 | Vumerity, Leqembi, Tysabri |
| Catalyst Pharmaceuticals, INC. | $194.31 | 2023-2025 | Fycompa |
| Alexion Pharmaceuticals, INC. | $154.93 | 2023-2025 | Ultomiris |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Ham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.